| Effects of intensive glucose lowering in type 2 diabetes Action to Control Cardiovascular Risk in Diabetes Study Group New England journal of medicine 358 (24), 2545-2559, 2008 | 9981 | 2008 |
| Evidence-based medicine: a new approach to teaching the practice of medicine G Guyatt, J Cairns, D Churchill, D Cook, B Haynes, J Hirsh, J Irvine, ... Jama 268 (17), 2420-2425, 1992 | 6754 | 1992 |
| Effects of intensive blood-pressure control in type 2 diabetes mellitus ACCORD Study Group New England Journal of Medicine 362 (17), 1575-1585, 2010 | 4417 | 2010 |
| Edmund Dunstan A Patel, S MacMahon, B Neal, L Billot Lancet 355, 253-58, 2000 | 3797 | 2000 |
| Effects of combination lipid therapy in type 2 diabetes mellitus ACCORD Study Group New England Journal of Medicine 362 (17), 1563-1574, 2010 | 3533 | 2010 |
| Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals HC Gerstein, JFE Mann, Q Yi, B Zinman, SF Dinneen, B Hoogwerf, ... Jama 286 (4), 421-426, 2001 | 3323 | 2001 |
| Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview SE Capes, D Hunt, K Malmberg, HC Gerstein The Lancet 355 (9206), 773-778, 2000 | 3087 | 2000 |
| Users' guides to the medical literature: III. How to use an article about a diagnostic test B. What are the results and will they help me in caring for my patients? R Jaeschke, GH Guyatt, DL Sackett, G Guyatt, E Bass, P Brill-Edwards, ... Jama 271 (9), 703-707, 1994 | 3087 | 1994 |
| The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. M Coutinho, HC Gerstein, Y Wang, S Yusuf Diabetes care 22 (2), 233-240, 1999 | 2726 | 1999 |
| Lixisenatide in patients with type 2 diabetes and acute coronary syndrome MA Pfeffer, B Claggett, R Diaz, K Dickstein, HC Gerstein, LV Køber, ... New England Journal of Medicine 373 (23), 2247-2257, 2015 | 2632 | 2015 |
| Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview SE Capes, D Hunt, K Malmberg, P Pathak, HC Gerstein Stroke 32 (10), 2426-2432, 2001 | 2608 | 2001 |
| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2556 | 2019 |
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ... The Lancet 368 (9541), 1096-1105, 2006 | 2284 | 2006 |
| Basal insulin and cardiovascular and other outcomes in dysglycemia ORIGIN Trial Investigators New England Journal of Medicine 367 (4), 319-328, 2012 | 2062 | 2012 |
| Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association JB Buse, HN Ginsberg, GL Bakris, NG Clark, F Costa, R Eckel, V Fonseca, ... Circulation 115 (1), 114-126, 2007 | 2038 | 2007 |
| Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial JFE Mann, HC Gerstein, J Pogue, J Bosch, S Yusuf, Hope Investigators Annals of internal medicine 134 (8), 629-636, 2001 | 1899 | 2001 |
| Users' guides to the medical literature: II. How to use an article about therapy or prevention A. Are the results of the study valid? GH Guyatt, DL Sackett, DJ Cook, G Guyatt, E Bass, P Brill-Edwards, ... Jama 270 (21), 2598-2601, 1993 | 1659 | 1993 |
| Effects of medical therapies on retinopathy progression in type 2 diabetes FLJ Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM ... New Engl J Med. 363 (3), 233-44, 2010 | 1636* | 2010 |
| Users' Guides to the Medical Literature: III. How to Use an Article About a Diagnostic Test A. Are the Results of the Study Valid? R Jaeschke, G Guyatt, DL Sackett, E Bass, P Brill-Edwards, G Browman, ... Jama 271 (5), 389-391, 1994 | 1594 | 1994 |
| Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies T Cukierman, HC Gerstein, JD Williamson Diabetologia 48, 2460-2469, 2005 | 1441 | 2005 |